These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37059355)

  • 41. Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.
    Mc Guire C; Elton L; Wieghofer P; Staal J; Voet S; Demeyer A; Nagel D; Krappmann D; Prinz M; Beyaert R; van Loo G
    J Neuroinflammation; 2014 Jul; 11():124. PubMed ID: 25043939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of TGF-β and EGF pathway gene expression and migration of oral carcinoma cells by mucosa-associated lymphoid tissue 1.
    Ohyama Y; Kawamoto Y; Chiba T; Maeda G; Sakashita H; Imai K
    Br J Cancer; 2013 Jul; 109(1):207-14. PubMed ID: 23778523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. USP2a positively regulates TCR-induced NF-κB activation by bridging MALT1-TRAF6.
    Li Y; He X; Wang S; Shu HB; Liu Y
    Protein Cell; 2013 Jan; 4(1):62-70. PubMed ID: 23264041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differing Requirements for MALT1 Function in Peripheral B Cell Survival and Differentiation.
    Lee P; Zhu Z; Hachmann J; Nojima T; Kitamura D; Salvesen G; Rickert RC
    J Immunol; 2017 Feb; 198(3):1066-1080. PubMed ID: 28031341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis.
    Dumont C; Sivars U; Andreasson T; Odqvist L; Mattsson J; DeMicco A; Pardali K; Johansson G; Yrlid L; Cox RJ; Seeliger F; Larsson M; Gehrmann U; Davis AM; Vaarala O
    PLoS One; 2020; 15(9):e0222548. PubMed ID: 32870913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Profiling the activity of the para-caspase MALT1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application.
    Safa FM; Rasmussen T; Fontan L; Xia M; Melnick A; Wiestner A; Lobelle-Rich P; Burger JA; Mouawad Y; Safah H; Flemington EK; Saba NS
    Haematologica; 2024 May; 109(5):1348-1358. PubMed ID: 37767562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth.
    Fontán L; Qiao Q; Hatcher JM; Casalena G; Us I; Teater M; Durant M; Du G; Xia M; Bilchuk N; Chennamadhavuni S; Palladino G; Inghirami G; Philippar U; Wu H; Scott DA; Gray NS; Melnick A
    J Clin Invest; 2018 Oct; 128(10):4397-4412. PubMed ID: 30024860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of recombinant and cellular MALT1 paracaspase activity.
    Nagel D; Krappmann D
    Methods Mol Biol; 2015; 1280():239-46. PubMed ID: 25736752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions.
    Noels H; van Loo G; Hagens S; Broeckx V; Beyaert R; Marynen P; Baens M
    J Biol Chem; 2007 Apr; 282(14):10180-9. PubMed ID: 17287209
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma.
    Wang L; Zhu R; Huang Z; Li H; Zhu H
    Dig Dis Sci; 2013 Aug; 58(8):2223-36. PubMed ID: 23828139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma.
    Dai B; Grau M; Juilland M; Klener P; Höring E; Molinsky J; Schimmack G; Aukema SM; Hoster E; Vogt N; Staiger AM; Erdmann T; Xu W; Erdmann K; Dzyuba N; Madle H; Berdel WE; Trneny M; Dreyling M; Jöhrens K; Lenz P; Rosenwald A; Siebert R; Tzankov A; Klapper W; Anagnostopoulos I; Krappmann D; Ott G; Thome M; Lenz G
    Blood; 2017 Jan; 129(3):333-346. PubMed ID: 27864294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice.
    Vicente-Dueñas C; Fontán L; Gonzalez-Herrero I; Romero-Camarero I; Segura V; Aznar MA; Alonso-Escudero E; Campos-Sanchez E; Ruiz-Roca L; Barajas-Diego M; Sagardoy A; Martinez-Ferrandis JI; Abollo-Jimenez F; Bertolo C; Peñuelas I; Garcia-Criado FJ; García-Cenador MB; Tousseyn T; Agirre X; Prosper F; Garcia-Bragado F; McPhail ED; Lossos IS; Du MQ; Flores T; Hernandez-Rivas JM; Gonzalez M; Salar A; Bellosillo B; Conde E; Siebert R; Sagaert X; Cobaleda C; Sanchez-Garcia I; Martinez-Climent JA
    Proc Natl Acad Sci U S A; 2012 Jun; 109(26):10534-9. PubMed ID: 22689981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.
    Ho L; Davis RE; Conne B; Chappuis R; Berczy M; Mhawech P; Staudt LM; Schwaller J
    Blood; 2005 Apr; 105(7):2891-9. PubMed ID: 15598810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
    Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
    J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma.
    Hailfinger S; Lenz G; Ngo V; Posvitz-Fejfar A; Rebeaud F; Guzzardi M; Penas EM; Dierlamm J; Chan WC; Staudt LM; Thome M
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19946-51. PubMed ID: 19897720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MALT1 is required for EGFR-induced NF-κB activation and contributes to EGFR-driven lung cancer progression.
    Pan D; Jiang C; Ma Z; Blonska M; You MJ; Lin X
    Oncogene; 2016 Feb; 35(7):919-28. PubMed ID: 25982276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Paracaspase MALT1.
    Hachmann J; Salvesen GS
    Biochimie; 2016 Mar; 122():324-38. PubMed ID: 26386283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The paracaspase MALT1: biological function and potential for therapeutic inhibition.
    Jaworski M; Thome M
    Cell Mol Life Sci; 2016 Feb; 73(3):459-73. PubMed ID: 26507244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Paracaspase MALT1 in Cancer.
    Gomez Solsona B; Schmitt A; Schulze-Osthoff K; Hailfinger S
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling.
    Elton L; Carpentier I; Staal J; Driege Y; Haegman M; Beyaert R
    FEBS J; 2016 Feb; 283(3):403-12. PubMed ID: 26573773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.